Newcastle-Bronchitis Vaccine, Bl Type, LaSota Strain, Mass Type, Live Virus Lyophilisate for solution for injection
Country: Saudi Arabia
Language: English
Source: SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Newcastle Bronchitis Virus B1 type LaSota strain and Infectious Bronchitis Virus Mass Type
INN (International Name):
Newcastle Bronchitis Virus B1 type LaSota strain and Infectious Bronchitis Virus Mass Type
Dosage:
Each dose contains: Newcastle-Bronchitis Virus B1 type LaSota strain 106.0 EID50 and Infectious Bronchitis Virus Mass Type 103.8 EID50 at the release. Each dose contains: Newcastle-Bronchitis Virus B1 type LaSota strain 105.5 EID50 and Infectious Br
Pharmaceutical form:
Lyophilisate for solution for injection
Administration route:
Intraocular use, Intranasal use, Drinking water
Units in package:
1000 Vial
Class:
Biological
Prescription type:
Uncontrolled
Product summary:
Storage conditions: dose
Authorization status:
Marketed; Valid
Authorization date:
2023-01-01
